Mannkind (MNKD) Cash from Investing Activities Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.02% |
| Dec 31, 2025 | -130.57% |
| Sep 30, 2025 | -474.62% |
| Jun 30, 2025 | 112.87% |
| Mar 31, 2025 | -21.38% |
| Dec 31, 2024 | 199.44% |
| Sep 30, 2024 | -66.95% |
| Jun 30, 2024 | -109.45% |
| Mar 31, 2024 | -14.11% |
| Dec 31, 2023 | -100.44% |
| Jun 30, 2022 | 142.72% |
| Mar 31, 2022 | -34.32% |
| Mar 31, 2021 | -94.56% |
| Dec 31, 2020 | -70.38% |
| Sep 30, 2020 | 67.79% |
| Jun 30, 2020 | 49.43% |
| Mar 31, 2020 | 46.39% |
| Dec 31, 2019 | 57.29% |
| Sep 30, 2019 | 80.82% |
| Jun 30, 2019 | 30.19% |
| Mar 31, 2019 | -77.80% |
| Dec 31, 2018 | 47.58% |
| Jun 30, 2017 | 17.98% |
| Mar 31, 2017 | 126.20% |
| Mar 31, 2016 | -21.19% |
| Dec 31, 2015 | 47.88% |
| Sep 30, 2015 | -35.65% |